Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

NantHealth, Inc. (NH) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 8-K Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran...
09/26/2023 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
08/15/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
07/27/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
05/26/2023 8-K Other Events  Interactive Data
05/23/2023 8-K Other Events  Interactive Data
05/22/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
05/01/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
04/14/2023 10-K Annual Report for the period ended December 31, 2022
03/31/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
03/06/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "NantHealth Announces $22.5 Million New Financing with Highbridge and Nant Capital"
12/15/2022 8-K Quarterly results
11/28/2022 8-K Quarterly results
11/04/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/03/2022 8-K Quarterly results
10/06/2022 8-K Quarterly results
09/07/2022 DEFA14C Form DEFA14C - Additional information statement materials, definitive:
08/24/2022 DEF 14C Form DEF 14C - Other definitive information statements:
08/19/2022 8-K Quarterly results
08/05/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
06/10/2022 4 BLASZYK MICHAEL D (Director) has filed a Form 4 on NantHealth, Inc.
Txns: Granted 100,000 options to buy @ $0.5823, valued at $58.2k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/05/2022 8-K Quarterly results
04/27/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
02/25/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
02/25/2022 10-K Annual Report for the period ended December 31, 2021
02/24/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy